Related Experiment Video

Updated: Jul 2, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Protein kinase CK2 as a druggable target

Stefania Sarno1, Lorenzo A Pinna

  • 1Department of Biological Chemistry, University of Padua and Venetian Institute for Molecular Medicine (VIMM), Padua, Italy.

Molecular Biosystems
|August 16, 2008
PubMed

Insights

Protein kinase CK2 (Casein kinase 2) is constitutively active and elevated in tumors, promoting cell survival. Inhibiting CK2 may offer a broad therapeutic strategy for various cancers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Casein kinase 2 (CK2) is a pleiotropic Ser/Thr protein kinase with numerous substrates involved in diverse cellular functions.
  • Unlike many kinases, CK2 exhibits constitutive activity, lacks tight regulation, and has no known mutations affecting its activity.
  • Elevated CK2 levels are consistently observed in tumors, suggesting a role in promoting cell survival and tumor development.

Purpose of the Study:

  • To investigate the role of CK2 in cancer.
  • To explore the therapeutic potential of targeting CK2 activity in neoplastic diseases.

Main Methods:

  • Review of existing literature on CK2 function and regulation.
  • Analysis of the association between CK2 levels and tumor phenotypes.
  • Evaluation of the potential of CK2 inhibitors as anti-cancer agents.

Main Results:

  • CK2 is implicated in a global pro-survival function that favors tumor development.
  • High CK2 levels create a cellular environment conducive to tumor potentiation.
  • Existing CK2 inhibitors show promise for therapeutic intervention.

Conclusions:

  • Attenuating CK2 activity represents a potential "master key" strategy for treating various cancers.
  • Further research into epigenetic mechanisms driving CK2 upregulation is warranted.
  • Development of potent and selective CK2 inhibitors is a valuable pharmacological approach for cancer therapy.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...